Vergleich

CD14 Protein

ArtNr OPPA01422
Hersteller AVIVA Systems Biology
Menge 10 ug
Kategorie
Typ Proteins Recombinant
Format Liquid
Specific against Human (Homo sapiens)
Host Hamster - Armenian
Purity Greater than 95.0% as determined by SDS-PAGE.
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Monocyte differentiation antigen CD14,Myeloid cell-specific leucine-rich glycoprotein,CD14,CD14 Human,CHO,CD14 Human Recombinant,CHO
Similar products CD14-CHO
Versandbedingung Raumtemperatur
Lieferbar
Manufacturer - Type
Protein
Manufacturer - Category
Root Catalog/Products/Recombinant Proteins
Shipping Temperature
Room Temperature
Gene symbol
CD14-CHO
Protein size
Recombinant
Product format
CD14 was lyophilized from a concentrated protein solution (1.0 mg/ml) containing phosphate-buffered saline, pH 7.2. Physical appearance: Sterile Filtered White lyophilized (freeze-dried) powder.
Reconstitution and storage
Reconstitution: It is recommended to reconstitute the lyophilized CD14 in sterile 18M Omega -cm H2O not less than 100 ug/ml. Further dilutions should be made with phosphate buffered saline (PBS).
Storage: Lyophilized CD14 although stable at room temperature for 3 weeks, should be stored desiccated below -18C. Upon reconstitution CD14 should be stored at 4C between 2-7 days and for future use below -18C. For long term storage it is recommended to add a carrier protein (0. 1% HSA or BSA). Please prevent freeze-thaw cycles.
Description of target
CD14 (also known lipopolysaccharide (LPS) receptor) is expressed strongly on monocytes and macrophage and weakly on the surface of neutrophils. CD14 is anchored to cells by linkage to glycosylphosphatidylinositol (GPI) and functions as a high affinity receptor for complexes of LPS and LPS binding protein (LBP). Soluble CD14, also binding to LPS, acts at physiological concentration as an LPS agonist and has, at higher concentrations, an LPS antagonizing effect in cell activation. CD14 has been shown to bind apoptotic cells.
Protein accession_num
NP_000582.1
Protein name
Monocyte differentiation antigen CD14
Biological activity
Up to 20 ug/ml CD14 inhibit binding of FITC-LPS (0.5 ug/ml) to 600, 000 CD14+CHO transfectants (FACS).

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 10 ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen